Relationship between HBsAg/HBV DNA and prognosis in patients with HBV-related hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors
PD-1/PD-L1 inhibitor therapy in patients with HBV-related HCC showed better efficacy and safety. Negative HBV DNA and a short-term decline in qHBsAg from baseline were associated with superior survival prognosis.
Authors
- Hongyan Liu (ORCID: https://orcid.org/0000-0003-0880-0945)
- Rong Fan (ORCID: https://orcid.org/0000-0002-5922-483X)
- Jinlin Hou (ORCID: https://orcid.org/0000-0001-8230-8583)
- Yuanyuan Zheng (ORCID: https://orcid.org/0000-0002-7595-1375)
- Xiaoyong Zhang (ORCID: https://orcid.org/0000-0002-6930-9423)
- Linlin Jin
- Yiran Wang (ORCID: https://orcid.org/0000-0002-9062-4751)
- Fei Zhou (ORCID: https://orcid.org/0000-0002-8691-916X)
- Dong Li (ORCID: https://orcid.org/0000-0003-1961-0581)
- Yabing Guo
- Qiuying Qin (ORCID: https://orcid.org/0009-0007-2549-9097)
- Mujia Zhu
Institutions
- Nanfang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251347469
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- National Natural Science Foundation of China